Toll Free: 1-888-928-9744

United States Anti-Infective Drugs Industry 2018 Market Research Report

Published: Feb 13, 2018 | Pages: 106 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the United States Anti-Infective Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Anti-Infective Drugs in these regions, from 2013 to 2025 (forecast).

United States Anti-Infective Drugs market competition by top manufacturers/players, with Anti-Infective Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    Merck
    Pfizer
    Novartis AG
    Gilead Sciences
    Abbott
    Wyeth
    Sanofi-Aventis
    Bristol-Myers Squibb
    Johnson
    Roche Pharma AG
    Nanosphere
    NanoViricides
    Novabay Pharmaceuticals
    Obetech
    Optimer Pharmaceuticals
    Basilea Pharmaceutica AG
    Daiichi Sankyo
    MerLion Pharma
    Theravance

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Antibiotic Drugs
    Antiviral Drugs
    Antifungal Drugs
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Home
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

United States Anti-Infective Drugs Market Report 2018
1 Anti-Infective Drugs Overview
    1.1 Product Overview and Scope of Anti-Infective Drugs
    1.2 Classification of Anti-Infective Drugs by Product Category
        1.2.1 United States Anti-Infective Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
        1.2.2 United States Anti-Infective Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
        1.2.3 Antibiotic Drugs
        1.2.4 Antiviral Drugs
        1.2.5 Antifungal Drugs
        1.2.6 Other
    1.3 United States Anti-Infective Drugs Market by Application/End Users
        1.3.1 United States Anti-Infective Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Home
        1.3.5 Other
    1.4 United States Anti-Infective Drugs Market by Region
        1.4.1 United States Anti-Infective Drugs Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 The West Anti-Infective Drugs Status and Prospect (2013-2025)
        1.4.3 Southwest Anti-Infective Drugs Status and Prospect (2013-2025)
        1.4.4 The Middle Atlantic Anti-Infective Drugs Status and Prospect (2013-2025)
        1.4.5 New England Anti-Infective Drugs Status and Prospect (2013-2025)
        1.4.6 The South Anti-Infective Drugs Status and Prospect (2013-2025)
        1.4.7 The Midwest Anti-Infective Drugs Status and Prospect (2013-2025)
    1.5 United States Market Size (Value and Volume) of Anti-Infective Drugs (2013-2025)
        1.5.1 United States Anti-Infective Drugs Sales and Growth Rate (2013-2025)
        1.5.2 United States Anti-Infective Drugs Revenue and Growth Rate (2013-2025)

2 United States Anti-Infective Drugs Market Competition by Players/Suppliers
    2.1 United States Anti-Infective Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
    2.2 United States Anti-Infective Drugs Revenue and Share by Players/Suppliers (2013-2018)
    2.3 United States Anti-Infective Drugs Average Price by Players/Suppliers (2013-2018)
    2.4 United States Anti-Infective Drugs Market Competitive Situation and Trends
        2.4.1 United States Anti-Infective Drugs Market Concentration Rate
        2.4.2 United States Anti-Infective Drugs Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Anti-Infective Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Anti-Infective Drugs Sales (Volume) and Revenue (Value) by Region (2013-2018)
    3.1 United States Anti-Infective Drugs Sales and Market Share by Region (2013-2018)
    3.2 United States Anti-Infective Drugs Revenue and Market Share by Region (2013-2018)
    3.3 United States Anti-Infective Drugs Price by Region (2013-2018)

4 United States Anti-Infective Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
    4.1 United States Anti-Infective Drugs Sales and Market Share by Type (Product Category) (2013-2018)
    4.2 United States Anti-Infective Drugs Revenue and Market Share by Type (2013-2018)
    4.3 United States Anti-Infective Drugs Price by Type (2013-2018)
    4.4 United States Anti-Infective Drugs Sales Growth Rate by Type (2013-2018)

5 United States Anti-Infective Drugs Sales (Volume) by Application (2013-2018)
    5.1 United States Anti-Infective Drugs Sales and Market Share by Application (2013-2018)
    5.2 United States Anti-Infective Drugs Sales Growth Rate by Application (2013-2018)
    5.3 Market Drivers and Opportunities

6  United States Anti-Infective Drugs Players/Suppliers Profiles and Sales Data
    6.1 GlaxoSmithKline
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Anti-Infective Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        6.1.4 Main Business/Business Overview
    6.2 Merck
        6.2.2 Anti-Infective Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        6.2.4 Main Business/Business Overview
    6.3 Pfizer
        6.3.2 Anti-Infective Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Pfizer Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        6.3.4 Main Business/Business Overview
    6.4 Novartis AG
        6.4.2 Anti-Infective Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Novartis AG Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        6.4.4 Main Business/Business Overview
    6.5 Gilead Sciences
        6.5.2 Anti-Infective Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Gilead Sciences Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        6.5.4 Main Business/Business Overview
    6.6 Abbott
        6.6.2 Anti-Infective Drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Abbott Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        6.6.4 Main Business/Business Overview
    6.7 Wyeth
        6.7.2 Anti-Infective Drugs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Wyeth Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        6.7.4 Main Business/Business Overview
    6.8 Sanofi-Aventis
        6.8.2 Anti-Infective Drugs Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Sanofi-Aventis Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        6.8.4 Main Business/Business Overview
    6.9 Bristol-Myers Squibb
        6.9.2 Anti-Infective Drugs Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Bristol-Myers Squibb Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        6.9.4 Main Business/Business Overview
    6.10 Johnson
        6.10.2 Anti-Infective Drugs Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Johnson Anti-Infective Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
        6.10.4 Main Business/Business Overview
    6.11 Roche Pharma AG
    6.12 Nanosphere
    6.13 NanoViricides
    6.14 Novabay Pharmaceuticals
    6.15 Obetech
    6.16 Optimer Pharmaceuticals
    6.17 Basilea Pharmaceutica AG
    6.18 Daiichi Sankyo
    6.19 MerLion Pharma
    6.20 Theravance

7 Anti-Infective Drugs Manufacturing Cost Analysis
    7.1 Anti-Infective Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Anti-Infective Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Anti-Infective Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Anti-Infective Drugs Major Manufacturers in 2017
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Anti-Infective Drugs Market Size (Value and Volume) Forecast (2018-2025)
    11.1 United States Anti-Infective Drugs Sales Volume, Revenue Forecast (2018-2025)
    11.2 United States Anti-Infective Drugs Sales Volume Forecast by Type (2018-2025)
    11.3 United States Anti-Infective Drugs Sales Volume Forecast by Application (2018-2025)
    11.4 United States Anti-Infective Drugs Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of Anti-Infective Drugs
    Figure United States Anti-Infective Drugs Market Size (K MT) by Type (2013-2025)
    Figure United States Anti-Infective Drugs Sales Volume Market Share by Type (Product Category) in 2017
    Figure Antibiotic Drugs Product Picture
    Figure Antiviral Drugs Product Picture
    Figure Antifungal Drugs Product Picture
    Figure Other Product Picture
    Figure United States Anti-Infective Drugs Market Size (K MT) by Application (2013-2025)
    Figure United States Sales Market Share of Anti-Infective Drugs by Application in 2017
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Clinic Examples
    Table Key Downstream Customer in Clinic
    Figure Home Examples
    Table Key Downstream Customer in Home
    Figure Other Examples
    Table Key Downstream Customer in Other
    Figure United States Anti-Infective Drugs Market Size (Million USD) by Region (2013-2025)
    Figure The West Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southwest Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Middle Atlantic Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure New England Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The South of US Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Midwest Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States Anti-Infective Drugs Sales (K MT) and Growth Rate (2013-2025)
    Figure United States Anti-Infective Drugs Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States Anti-Infective Drugs Market Major Players Product Sales Volume (K MT) (2013-2018)
    Table United States Anti-Infective Drugs Sales (K MT) of Key Players/Suppliers (2013-2018)
    Table United States Anti-Infective Drugs Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 United States Anti-Infective Drugs Sales Share by Players/Suppliers
    Figure 2017 United States Anti-Infective Drugs Sales Share by Players/Suppliers
    Figure United States Anti-Infective Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
    Table United States Anti-Infective Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table United States Anti-Infective Drugs Revenue Share by Players/Suppliers (2013-2018)
    Figure 2017 United States Anti-Infective Drugs Revenue Share by Players/Suppliers
    Figure 2017 United States Anti-Infective Drugs Revenue Share by Players/Suppliers
    Table United States Market Anti-Infective Drugs Average Price (USD/MT) of Key Players/Suppliers (2013-2018)
    Figure United States Market Anti-Infective Drugs Average Price (USD/MT) of Key Players/Suppliers in 2017
    Figure United States Anti-Infective Drugs Market Share of Top 3 Players/Suppliers
    Figure United States Anti-Infective Drugs Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Anti-Infective Drugs Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Anti-Infective Drugs Product Category
    Table United States Anti-Infective Drugs Sales (K MT) by Region (2013-2018)
    Table United States Anti-Infective Drugs Sales Share by Region (2013-2018)
    Figure United States Anti-Infective Drugs Sales Share by Region (2013-2018)
    Figure United States Anti-Infective Drugs Sales Market Share by Region in 2017
    Table United States Anti-Infective Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
    Table United States Anti-Infective Drugs Revenue Share by Region (2013-2018)
    Figure United States Anti-Infective Drugs Revenue Market Share by Region (2013-2018)
    Figure United States Anti-Infective Drugs Revenue Market Share by Region in 2017
    Table United States Anti-Infective Drugs Price (USD/MT) by Region (2013-2018)
    Table United States Anti-Infective Drugs Sales (K MT) by Type (2013-2018)
    Table United States Anti-Infective Drugs Sales Share by Type (2013-2018)
    Figure United States Anti-Infective Drugs Sales Share by Type (2013-2018)
    Figure United States Anti-Infective Drugs Sales Market Share by Type in 2017
    Table United States Anti-Infective Drugs Revenue  (Million USD) and Market Share by Type (2013-2018)
    Table United States Anti-Infective Drugs Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Anti-Infective Drugs by Type (2013-2018)
    Figure Revenue Market Share of Anti-Infective Drugs by Type in 2017
    Table United States Anti-Infective Drugs Price (USD/MT) by Types (2013-2018)
    Figure United States Anti-Infective Drugs Sales Growth Rate by Type (2013-2018)
    Table United States Anti-Infective Drugs Sales (K MT) by Application (2013-2018)
    Table United States Anti-Infective Drugs Sales Market Share by Application (2013-2018)
    Figure United States Anti-Infective Drugs Sales Market Share by Application (2013-2018)
    Figure United States Anti-Infective Drugs Sales Market Share by Application in 2017
    Table United States Anti-Infective Drugs Sales Growth Rate by Application (2013-2018)
    Figure United States Anti-Infective Drugs Sales Growth Rate by Application (2013-2018)
    Table GlaxoSmithKline Basic Information List
    Table GlaxoSmithKline Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
    Figure GlaxoSmithKline Anti-Infective Drugs Sales Growth Rate (2013-2018)
    Figure GlaxoSmithKline Anti-Infective Drugs Sales Market Share in United States (2013-2018)
    Figure GlaxoSmithKline Anti-Infective Drugs Revenue Market Share in United States (2013-2018)
    Table Merck Basic Information List
    Table Merck Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Merck Anti-Infective Drugs Sales Growth Rate (2013-2018)
    Figure Merck Anti-Infective Drugs Sales Market Share in United States (2013-2018)
    Figure Merck Anti-Infective Drugs Revenue Market Share in United States (2013-2018)
    Table Pfizer Basic Information List
    Table Pfizer Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Pfizer Anti-Infective Drugs Sales Growth Rate (2013-2018)
    Figure Pfizer Anti-Infective Drugs Sales Market Share in United States (2013-2018)
    Figure Pfizer Anti-Infective Drugs Revenue Market Share in United States (2013-2018)
    Table Novartis AG Basic Information List
    Table Novartis AG Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Novartis AG Anti-Infective Drugs Sales Growth Rate (2013-2018)
    Figure Novartis AG Anti-Infective Drugs Sales Market Share in United States (2013-2018)
    Figure Novartis AG Anti-Infective Drugs Revenue Market Share in United States (2013-2018)
    Table Gilead Sciences Basic Information List
    Table Gilead Sciences Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Gilead Sciences Anti-Infective Drugs Sales Growth Rate (2013-2018)
    Figure Gilead Sciences Anti-Infective Drugs Sales Market Share in United States (2013-2018)
    Figure Gilead Sciences Anti-Infective Drugs Revenue Market Share in United States (2013-2018)
    Table Abbott Basic Information List
    Table Abbott Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Abbott Anti-Infective Drugs Sales Growth Rate (2013-2018)
    Figure Abbott Anti-Infective Drugs Sales Market Share in United States (2013-2018)
    Figure Abbott Anti-Infective Drugs Revenue Market Share in United States (2013-2018)
    Table Wyeth Basic Information List
    Table Wyeth Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Wyeth Anti-Infective Drugs Sales Growth Rate (2013-2018)
    Figure Wyeth Anti-Infective Drugs Sales Market Share in United States (2013-2018)
    Figure Wyeth Anti-Infective Drugs Revenue Market Share in United States (2013-2018)
    Table Sanofi-Aventis Basic Information List
    Table Sanofi-Aventis Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Sanofi-Aventis Anti-Infective Drugs Sales Growth Rate (2013-2018)
    Figure Sanofi-Aventis Anti-Infective Drugs Sales Market Share in United States (2013-2018)
    Figure Sanofi-Aventis Anti-Infective Drugs Revenue Market Share in United States (2013-2018)
    Table Bristol-Myers Squibb Basic Information List
    Table Bristol-Myers Squibb Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Bristol-Myers Squibb Anti-Infective Drugs Sales Growth Rate (2013-2018)
    Figure Bristol-Myers Squibb Anti-Infective Drugs Sales Market Share in United States (2013-2018)
    Figure Bristol-Myers Squibb Anti-Infective Drugs Revenue Market Share in United States (2013-2018)
    Table Johnson Basic Information List
    Table Johnson Anti-Infective Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
    Figure Johnson Anti-Infective Drugs Sales Growth Rate (2013-2018)
    Figure Johnson Anti-Infective Drugs Sales Market Share in United States (2013-2018)
    Figure Johnson Anti-Infective Drugs Revenue Market Share in United States (2013-2018)
    Table Roche Pharma AG Basic Information List
    Table Nanosphere Basic Information List
    Table NanoViricides Basic Information List
    Table Novabay Pharmaceuticals Basic Information List
    Table Obetech Basic Information List
    Table Optimer Pharmaceuticals Basic Information List
    Table Basilea Pharmaceutica AG Basic Information List
    Table Daiichi Sankyo Basic Information List
    Table MerLion Pharma Basic Information List
    Table Theravance Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Anti-Infective Drugs
    Figure Manufacturing Process Analysis of Anti-Infective Drugs
    Figure Anti-Infective Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Anti-Infective Drugs Major Players/Suppliers in 2017
    Table Major Buyers of Anti-Infective Drugs
    Table Distributors/Traders List
    Figure United States Anti-Infective Drugs Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
    Figure United States Anti-Infective Drugs Revenue  (Million USD) and Growth Rate Forecast (2018-2025)
    Figure United States Anti-Infective Drugs Price (USD/MT) Trend Forecast (2018-2025)
    Table United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Type (2018-2025)
    Figure United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Type (2018-2025)
    Figure United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Type in 2025
    Table United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Application (2018-2025)
    Figure United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Application (2018-2025)
    Figure United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Application in 2025
    Table United States Anti-Infective Drugs Sales Volume (K MT) Forecast by Region (2018-2025)
    Table United States Anti-Infective Drugs Sales Volume Share Forecast by Region (2018-2025)
    Figure United States Anti-Infective Drugs Sales Volume Share Forecast by Region (2018-2025)
    Figure United States Anti-Infective Drugs Sales Volume Share Forecast by Region in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing ap

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...

Global geotextile market size is likely to be valued at USD 8.24 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing use in soil reinforcement activity coupled with growing application scope in road & railway developmen

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

To learn more about this report, request a free sample copy

Choose License Type
Single User - US $3800
Multi User - US $7600
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify